Literature DB >> 2818916

Extrahepatic morphine metabolism in man during the anhepatic phase of orthotopic liver transplantation.

A Bodenham1, K Quinn, G R Park.   

Abstract

The primary site for the metabolism of morphine has been the subject of controversy for some time. We studied morphine metabolism during the anhepatic phase of orthotopic liver transplantation in seven adult patients. After injection of morphine 10 mg at the beginning of this phase, the plasma and urinary concentrations of unchanged morphine, morphine-3-glucuronide, morphine-6-glucuronide and normorphine were measured by high pressure liquid chromatography. Small but measurable concentrations of morphine metabolites were found in the plasma and urine whilst there was no functional liver tissue in the body. Morphine metabolism increased markedly when the new donor liver was reperfused. This suggests that, in these patients, the liver is the primary site for metabolism of morphine.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2818916     DOI: 10.1093/bja/63.4.380

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  11 in total

1.  Altered morphine glucuronide and bile acid disposition in patients with nonalcoholic steatohepatitis.

Authors:  B C Ferslew; C K Johnston; E Tsakalozou; A S Bridges; M F Paine; W Jia; P W Stewart; A S Barritt; K L R Brouwer
Journal:  Clin Pharmacol Ther       Date:  2015-03-15       Impact factor: 6.875

Review 2.  Morphine-6-glucuronide: an analgesic of the future?

Authors:  J Lötsch; G Geisslinger
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

3.  Morphine-6beta-glucuronide modulates the expression of inducible nitric oxide synthase.

Authors:  D T Lysle; K A Carrigan
Journal:  Inflammation       Date:  2001-08       Impact factor: 4.092

4.  Morphine pharmacokinetics and metabolism in humans. Enterohepatic cycling and relative contribution of metabolites to active opioid concentrations.

Authors:  J Hasselström; J Säwe
Journal:  Clin Pharmacokinet       Date:  1993-04       Impact factor: 6.447

Review 5.  Effect of hepatic insufficiency on pharmacokinetics and drug dosing.

Authors:  R K Verbeeck; Y Horsmans
Journal:  Pharm World Sci       Date:  1998-10

Review 6.  Extrahepatic metabolism of drugs in humans.

Authors:  D R Krishna; U Klotz
Journal:  Clin Pharmacokinet       Date:  1994-02       Impact factor: 6.447

Review 7.  The use of sedative agents in critically ill patients.

Authors:  A M Burns; M P Shelly; G R Park
Journal:  Drugs       Date:  1992-04       Impact factor: 9.546

8.  Blood concentrations of dopexamine in patients during and after orthotopic liver transplantation.

Authors:  P A Gray; T Jones; G R Park
Journal:  Br J Clin Pharmacol       Date:  1994-01       Impact factor: 4.335

9.  Morphine: pharmacokinetics and clinical practice.

Authors:  P J Hoskin; G W Hanks
Journal:  Br J Cancer       Date:  1990-11       Impact factor: 7.640

Review 10.  Morphine for the treatment of pain in sickle cell disease.

Authors:  Mihir Gupta; Lilian Msambichaka; Samir K Ballas; Kalpna Gupta
Journal:  ScientificWorldJournal       Date:  2015-01-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.